Author

ME Linnaus

Institutions: Translational Genomics Research Institute, Merck & Co., Inc., Rahway, NJ, USA (United States), Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital, Arizona State University

Observed institutions: Translational Genomics Research Institute, Merck & Co., Inc., Rahway, NJ, USA (United States), Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital, Arizona State University

OpenAlex ID: A5052196817

Abstract PD5-03: Effect of PD-1 and PD-L1 in the tumor microenvironment on overall survival of triple-negative breast cancer patients

2017 · ME Linnaus, H Kosiorek, et al. · Cancer Research

Abstract P1-05-19: Homologous recombination deficiency in PD-L1, PD-L2, Jak2 (PDJ) amplified triple negative breast carcinoma

2017 · CD Gawryletz, KS Anderson, et al. · Cancer Research

Abstract P1-03-13: Immunohistochemistry cannot be used to detect PD-L1/JAK-2 amplification

2017 · ME Linnaus, H Kosiorek, et al. · Cancer Research

Works count: 3

Citation count:

H-index:

I10-index: